KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Stereotaxis (STXS) Current Deferred Revenue (2016 - 2025)

Stereotaxis (STXS) has disclosed Current Deferred Revenue for 16 consecutive years, with $7.5 million as the latest value for Q3 2025.

  • On a quarterly basis, Current Deferred Revenue rose 48.06% to $7.5 million in Q3 2025 year-over-year; TTM through Sep 2025 was $7.5 million, a 48.06% increase, with the full-year FY2024 number at $6.8 million, down 17.96% from a year prior.
  • Current Deferred Revenue was $7.5 million for Q3 2025 at Stereotaxis, up from $5.8 million in the prior quarter.
  • In the past five years, Current Deferred Revenue ranged from a high of $9.0 million in Q4 2022 to a low of $5.1 million in Q3 2024.
  • A 5-year average of $7.2 million and a median of $7.5 million in 2025 define the central range for Current Deferred Revenue.
  • Peak YoY movement for Current Deferred Revenue: decreased 22.72% in 2023, then surged 48.06% in 2025.
  • Stereotaxis' Current Deferred Revenue stood at $6.3 million in 2021, then soared by 43.32% to $9.0 million in 2022, then fell by 7.8% to $8.3 million in 2023, then fell by 17.96% to $6.8 million in 2024, then rose by 10.8% to $7.5 million in 2025.
  • Per Business Quant, the three most recent readings for STXS's Current Deferred Revenue are $7.5 million (Q3 2025), $5.8 million (Q2 2025), and $6.8 million (Q4 2024).